Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
GSK routinely monitors the safety of all its medicines and vaccines.
This includes review of safety data from clinical studies, and collection of reports and cases of suspected side effects for marketed products.
The information contributes to the continuing safety surveillance of our products. If you become aware of a patient who has experienced an adverse event, pregnancy, overdose or unexpected benefits with one of our products, we would be grateful if you would report this to us as outlined below.
How to report a possible side effect?
To help us process your information quickly and effectively, please remember to report as much relevant information as possible. At a minimum you will need to provide the following:
- The initials of the person who experienced the possible side effect and/or other identifiers, such as gender, date of birth.
- The contact information of the reporter, namely the person who is reporting the issue.
- A description of the possible side effect itself, such as the signs and symptoms experienced, date the possible side effect started and the result of the possible side effect.
- The name of the GSK/ViiV product involved.
Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.
To report an adverse event:
Either call us at 1800 244 255 or send an email to ireland.drugsurveillance@gsk.com.
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
